EXGILIA
"EXGILIA" is a word mark owned by Ipsen Pharma S.A.S., filed at the USPTO on July 8, 2026. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since October 27, 2026
- Filed
- July 8, 2026
- Registered
- October 27, 2026
- Expires
- Not recorded
- Application no.
- 99928541
- Registration no.
- 8524161
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns EXGILIA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Ipsen Pharma S.A.S.
Paris, France
Representative
Ben Natter
Haug Partners, LLP
What the mark covers
The products and services EXGILIA is filed for, grouped by Nice class.
Pharmaceutical preparations for use in the diagnosis, treatment, or prevention of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, hematological diseases and disorders, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain; pharmaceutical preparations for aesthetic and therapeutic use, including for the diagnosis, treatment, or prevention of glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations for skin care.
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Teas response to office action received
- Notification of non-final action e-mailed
6 earlier steps on the official record.
About EXGILIA
Who owns the trademark "EXGILIA"?
The USPTO trademark "EXGILIA" (application 99928541) is owned by Ipsen Pharma S.A.S.
What is the status of "EXGILIA"?
Its status at the USPTO is: registered.
When was "EXGILIA" registered?
It was registered on October 27, 2026.
Get this data via the API
Everything on this page comes from the Signa API. Pull EXGILIA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019f4701-43b8-727e-9eea-f44307a24a27
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019f4701-43b8-727e-9eea-f44307a24a27",
"object": "trademark",
"mark_text": "EXGILIA",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "99928541",
"filing_date": "2026-07-08",
"nice_classes": [
5
],
"owners": [
{
"name": "Ipsen Pharma S.A.S.",
"entity_id": "ent_019eb6f9-ad85-75c4-94ee-581599ed8d81"
}
]
}